Frequencies for first 10,000 rows of indi_pt variable in indi2005q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL PAIN | 6 0.06 0.06 ABDOMINAL PAIN LOWER | 1 0.01 0.07 ABDOMINAL PAIN UPPER | 4 0.04 0.11 ABNORMAL BEHAVIOUR | 6 0.06 0.17 ABORTION INDUCED | 4 0.04 0.21 ABSCESS | 1 0.01 0.22 ACCIDENTAL EXPOSURE | 1 0.01 0.23 ACINETOBACTER INFECTION | 3 0.03 0.26 ACNE | 25 0.25 0.51 ACQUIRED IMMUNODEFICIENCY SYNDROME | 6 0.06 0.57 ACROMEGALY | 4 0.04 0.61 ACTINIC KERATOSIS | 3 0.03 0.64 ACUTE CORONARY SYNDROME | 3 0.03 0.67 ACUTE LEUKAEMIA | 1 0.01 0.68 ACUTE LYMPHOCYTIC LEUKAEMIA | 77 0.77 1.45 ACUTE MONOCYTIC LEUKAEMIA | 2 0.02 1.47 ACUTE MYELOID LEUKAEMIA | 16 0.16 1.63 ACUTE MYOCARDIAL INFARCTION | 2 0.02 1.65 ACUTE PROMYELOCYTIC LEUKAEMIA | 4 0.04 1.69 ACUTE PSYCHOSIS | 1 0.01 1.70 ACUTE RESPIRATORY DISTRESS SYNDROME | 1 0.01 1.71 ACUTE SINUSITIS | 1 0.01 1.72 ADENOCARCINOMA | 4 0.04 1.76 ADENOID CYSTIC CARCINOMA | 2 0.02 1.78 ADJUSTMENT DISORDER | 1 0.01 1.79 ADRENOCORTICAL STEROID THERAPY | 1 0.01 1.80 AFFECT LABILITY | 2 0.02 1.82 AFFECTIVE DISORDER | 4 0.04 1.86 AGGRESSION | 2 0.02 1.88 AGITATION | 6 0.06 1.94 ALCOHOLISM | 4 0.04 1.98 ALOPECIA | 3 0.03 2.01 AMNESIA | 48 0.48 2.49 AMYLOIDOSIS | 4 0.04 2.53 ANAEMIA | 8 0.08 2.61 ANAEMIA PROPHYLAXIS | 1 0.01 2.62 ANAESTHESIA | 14 0.14 2.76 ANAESTHETIC PREMEDICATION | 1 0.01 2.77 ANALGESIC EFFECT | 5 0.05 2.82 ANALGESIC THERAPY | 3 0.03 2.85 ANGINA PECTORIS | 21 0.21 3.06 ANGINA UNSTABLE | 1 0.01 3.07 ANGIOGRAM | 2 0.02 3.09 ANGIOGRAM RETINA | 1 0.01 3.10 ANGIOPLASTY | 1 0.01 3.11 ANISAKIASIS | 1 0.01 3.12 ANKYLOSING SPONDYLITIS | 10 0.10 3.22 ANOREXIA | 2 0.02 3.24 ANTIBACTERIAL PROPHYLAXIS | 4 0.04 3.28 ANTICOAGULANT THERAPY | 18 0.18 3.46 ANTIEMETIC SUPPORTIVE CARE | 2 0.02 3.48 ANTIINFLAMMATORY THERAPY | 1 0.01 3.49 ANTIPLATELET THERAPY | 2 0.02 3.51 ANTITUSSIVE THERAPY | 1 0.01 3.52 ANTIVIRAL PROPHYLAXIS | 6 0.06 3.58 ANXIETY | 78 0.78 4.36 ANXIETY DISORDER | 1 0.01 4.37 AORTIC ANEURYSM | 1 0.01 4.38 AORTIC SURGERY | 1 0.01 4.39 AORTIC VALVE INCOMPETENCE | 2 0.02 4.41 AORTIC VALVE REPAIR | 2 0.02 4.43 AORTIC VALVE REPLACEMENT | 1 0.01 4.44 APHASIA | 11 0.11 4.55 APLASTIC ANAEMIA | 3 0.03 4.58 ARRHYTHMIA | 10 0.10 4.68 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 4.70 ARTERIOGRAM CORONARY | 1 0.01 4.71 ARTERIOSCLEROTIC RETINOPATHY | 1 0.01 4.72 ARTHRALGIA | 26 0.26 4.98 ARTHRITIS | 77 0.77 5.75 ARTHROPATHY | 2 0.02 5.77 ASBESTOSIS | 1 0.01 5.78 ASPERGER'S DISORDER | 2 0.02 5.80 ASPERGILLOSIS | 6 0.06 5.86 ASPIRATION BONE MARROW | 4 0.04 5.90 ASTHMA | 189 1.89 7.79 ATHEROSCLEROSIS OBLITERANS | 3 0.03 7.82 ATRIAL FIBRILLATION | 37 0.37 8.19 ATRIAL FLUTTER | 2 0.02 8.21 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 12 0.12 8.33 ATYPICAL MYCOBACTERIAL INFECTION | 3 0.03 8.36 AUTISM | 1 0.01 8.37 AUTOIMMUNE HEPATITIS | 2 0.02 8.39 AUTOIMMUNE THYROIDITIS | 1 0.01 8.40 B PRECURSOR TYPE ACUTE LEUKAEMIA | 1 0.01 8.41 B-CELL LYMPHOMA | 6 0.06 8.47 BABESIOSIS | 2 0.02 8.49 BACK DISORDER | 5 0.05 8.54 BACK INJURY | 2 0.02 8.56 BACK PAIN | 47 0.47 9.03 BARRETT'S OESOPHAGUS | 1 0.01 9.04 BASAL CELL CARCINOMA | 1 0.01 9.05 BEHCET'S SYNDROME | 1 0.01 9.06 BENIGN PROSTATIC HYPERPLASIA | 22 0.22 9.28 BILE DUCT CANCER | 3 0.03 9.31 BIPOLAR DISORDER | 34 0.34 9.65 BIPOLAR I DISORDER | 8 0.08 9.73 BIPOLAR II DISORDER | 1 0.01 9.74 BLADDER CANCER | 8 0.08 9.82 BLADDER DISORDER | 2 0.02 9.84 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 9.85 BLEPHAROSPASM | 5 0.05 9.90 BLOOD CHOLESTEROL | 5 0.05 9.95 BLOOD CHOLESTEROL INCREASED | 311 3.11 13.06 BLOOD GROWTH HORMONE | 1 0.01 13.07 BLOOD HOMOCYSTEINE ABNORMAL | 1 0.01 13.08 BLOOD POTASSIUM DECREASED | 1 0.01 13.09 BLOOD PRESSURE | 5 0.05 13.14 BLOOD PRESSURE ABNORMAL | 1 0.01 13.15 BLOOD PRESSURE INCREASED | 6 0.06 13.21 BLOOD TESTOSTERONE DECREASED | 2 0.02 13.23 BLOOD TRIGLYCERIDES | 2 0.02 13.25 BLOOD TRIGLYCERIDES INCREASED | 5 0.05 13.30 BODY HEIGHT BELOW NORMAL | 1 0.01 13.31 BODY HEIGHT DECREASED | 1 0.01 13.32 BONE DENSITY DECREASED | 6 0.06 13.38 BONE DISORDER | 10 0.10 13.48 BONE LESION | 1 0.01 13.49 BONE MARROW TRANSPLANT | 1 0.01 13.50 BONE NEOPLASM MALIGNANT | 1 0.01 13.51 BONE PAIN | 3 0.03 13.54 BORDERLINE PERSONALITY DISORDER | 5 0.05 13.59 BRAIN NEOPLASM | 1 0.01 13.60 BRAIN OEDEMA | 1 0.01 13.61 BREAST CANCER | 48 0.48 14.09 BREAST CANCER METASTATIC | 21 0.21 14.30 BREAST CANCER RECURRENT | 1 0.01 14.31 BRONCHIAL CARCINOMA | 2 0.02 14.33 BRONCHIECTASIS | 6 0.06 14.39 BRONCHIOLITIS | 1 0.01 14.40 BRONCHITIS | 36 0.36 14.76 BRONCHITIS ACUTE | 7 0.07 14.83 BRONCHITIS CHRONIC | 3 0.03 14.86 BRONCHOPNEUMONIA | 1 0.01 14.87 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 14.90 BRONCHOSPASM | 2 0.02 14.92 BRUCELLOSIS | 1 0.01 14.93 BURKITT'S LYMPHOMA | 64 0.64 15.57 BURKITT'S LYMPHOMA STAGE II | 4 0.04 15.61 BURSITIS | 1 0.01 15.62 BUTTOCK PAIN | 1 0.01 15.63 CALCINOSIS | 1 0.01 15.64 CALCIUM DEFICIENCY | 1 0.01 15.65 CALCULUS URETERIC | 1 0.01 15.66 CANCER PAIN | 3 0.03 15.69 CANDIDIASIS | 2 0.02 15.71 CARCINOID TUMOUR | 1 0.01 15.72 CARCINOID TUMOUR OF THE SMALL BOWEL | 1 0.01 15.73 CARDIAC ANEURYSM REPAIR | 1 0.01 15.74 CARDIAC DISORDER | 8 0.08 15.82 CARDIAC FAILURE | 7 0.07 15.89 CARDIAC FAILURE ACUTE | 1 0.01 15.90 CARDIAC FAILURE CHRONIC | 1 0.01 15.91 CARDIAC FAILURE CONGESTIVE | 9 0.09 16.00 CARDIAC OPERATION | 2 0.02 16.02 CARDIOMEGALY | 1 0.01 16.03 CARDIOVASCULAR DISORDER | 50 0.50 16.53 CARDIOVERSION | 1 0.01 16.54 CARPAL TUNNEL SYNDROME | 2 0.02 16.56 CATARACT | 2 0.02 16.58 CATARACT SUBCAPSULAR | 1 0.01 16.59 CATHETER PLACEMENT | 1 0.01 16.60 CATHETERISATION CARDIAC | 3 0.03 16.63 CELLULITIS | 4 0.04 16.67 CENTRAL NERVOUS SYSTEM LYMPHOMA | 10 0.10 16.77 CEREBRAL INFARCTION | 2 0.02 16.79 CEREBRAL ISCHAEMIA | 1 0.01 16.80 CEREBRAL PALSY | 1 0.01 16.81 CEREBRAL TOXOPLASMOSIS | 3 0.03 16.84 CEREBROVASCULAR ACCIDENT | 5 0.05 16.89 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 47 0.47 17.36 CERVICAL VERTEBRA INJURY | 1 0.01 17.37 CERVICOBRACHIAL SYNDROME | 1 0.01 17.38 CERVIX CARCINOMA | 4 0.04 17.42 CHEMICAL POISONING | 1 0.01 17.43 CHEMOTHERAPY | 21 0.21 17.64 CHEST PAIN | 4 0.04 17.68 CHLAMYDIAL INFECTION | 2 0.02 17.70 CHOLECYSTECTOMY | 1 0.01 17.71 CHROMOSOME ABNORMALITY | 1 0.01 17.72 CHRONIC FATIGUE SYNDROME | 1 0.01 17.73 CHRONIC LYMPHOCYTIC LEUKAEMIA | 18 0.18 17.91 CHRONIC MYELOID LEUKAEMIA | 13 0.13 18.04 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 4 0.04 18.08 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 430 4.30 22.38 CHRONIC SINUSITIS | 1 0.01 22.39 CHYLOTHORAX | 1 0.01 22.40 CLAVICLE FRACTURE | 1 0.01 22.41 CLOSTRIDIUM COLITIS | 2 0.02 22.43 COAGULOPATHY | 16 0.16 22.59 COGNITIVE DISORDER | 2 0.02 22.61 COLITIS ULCERATIVE | 6 0.06 22.67 COLON CANCER | 63 0.63 23.30 COLON CANCER METASTATIC | 12 0.12 23.42 COLON CANCER STAGE III | 6 0.06 23.48 COLORECTAL CANCER | 26 0.26 23.74 COLORECTAL CANCER METASTATIC | 29 0.29 24.03 COMPLEX PARTIAL SEIZURES | 2 0.02 24.05 COMPRESSION FRACTURE | 1 0.01 24.06 COMPUTERISED TOMOGRAM | 11 0.11 24.17 COMPUTERISED TOMOGRAM ABDOMEN | 9 0.09 24.26 COMPUTERISED TOMOGRAM THORAX | 2 0.02 24.28 CONDITION AGGRAVATED | 2 0.02 24.30 CONJUNCTIVITIS | 2 0.02 24.32 CONJUNCTIVITIS ALLERGIC | 1 0.01 24.33 CONNECTIVE TISSUE DISORDER | 2 0.02 24.35 CONSTIPATION | 51 0.51 24.86 CONTRACEPTION | 141 1.41 26.27 CONTUSION | 1 0.01 26.28 CONVULSION | 61 0.61 26.89 CONVULSION PROPHYLAXIS | 1 0.01 26.90 CORD BLOOD TRANSPLANT THERAPY | 1 0.01 26.91 CORNEAL ENDOTHELIITIS | 2 0.02 26.93 CORNEAL TRANSPLANT | 1 0.01 26.94 CORONARY ANGIOPLASTY | 13 0.13 27.07 CORONARY ARTERIAL STENT INSERTION | 4 0.04 27.11 CORONARY ARTERY DISEASE | 16 0.16 27.27 CORONARY ARTERY OCCLUSION | 1 0.01 27.28 CORONARY ARTERY SURGERY | 8 0.08 27.36 CORONARY ARTERY THROMBOSIS | 2 0.02 27.38 COUGH | 8 0.08 27.46 CROHN'S DISEASE | 46 0.46 27.92 CULTURE POSITIVE | 1 0.01 27.93 CUTANEOUS LEISHMANIASIS | 3 0.03 27.96 CYSTITIS | 4 0.04 28.00 CYSTITIS INTERSTITIAL | 1 0.01 28.01 DEATH | 2 0.02 28.03 DECREASED APPETITE | 1 0.01 28.04 DECUBITUS ULCER | 1 0.01 28.05 DEEP VEIN THROMBOSIS | 2 0.02 28.07 DEHYDRATION | 4 0.04 28.11 DELIRIUM | 1 0.01 28.12 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 28.13 DEMENTIA | 175 1.75 29.88 DEMENTIA ALZHEIMER'S TYPE | 264 2.64 32.52 DENTAL CARE | 1 0.01 32.53 DENTAL DISORDER PROPHYLAXIS | 1 0.01 32.54 DEPRESSION | 199 1.99 34.53 DERMATITIS ATOPIC | 2 0.02 34.55 DERMATITIS INFECTED | 1 0.01 34.56 DERMATOMYOSITIS | 1 0.01 34.57 DIABETES MELLITUS | 96 0.96 35.53 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 35.54 DIABETES MELLITUS INSULIN-DEPENDENT | 20 0.20 35.74 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 25 0.25 35.99 DIABETIC COMPLICATION | 1 0.01 36.00 DIABETIC GANGRENE | 1 0.01 36.01 DIABETIC GASTROPARESIS | 1 0.01 36.02 DIABETIC NEPHROPATHY | 1 0.01 36.03 DIABETIC NEUROPATHY | 1 0.01 36.04 DIAGNOSTIC PROCEDURE | 3 0.03 36.07 DIALYSIS | 2 0.02 36.09 DIARRHOEA | 6 0.06 36.15 DIFFUSE LARGE B-CELL LYMPHOMA | 5 0.05 36.20 DISCOMFORT | 1 0.01 36.21 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 36.22 DIURETIC THERAPY | 3 0.03 36.25 DIVERTICULITIS | 3 0.03 36.28 DIVERTICULUM | 1 0.01 36.29 DIZZINESS | 1 0.01 36.30 DRUG ABUSER | 2 0.02 36.32 DRUG DEPENDENCE | 2 0.02 36.34 DRUG ERUPTION | 1 0.01 36.35 DRUG EXPOSURE DURING PREGNANCY | 3 0.03 36.38 DRUG THERAPY | 2 0.02 36.40 DRUG USE FOR UNKNOWN INDICATION | 514 5.14 41.54 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 41.55 DUODENAL ULCER | 2 0.02 41.57 DYSLIPIDAEMIA | 24 0.24 41.81 DYSMENORRHOEA | 5 0.05 41.86 DYSPEPSIA | 10 0.10 41.96 DYSPNOEA | 9 0.09 42.05 DYSPNOEA EXERTIONAL | 1 0.01 42.06 DYSTHYMIC DISORDER | 1 0.01 42.07 EAR INFECTION | 2 0.02 42.09 EAR PAIN | 6 0.06 42.15 ECZEMA | 7 0.07 42.22 ELECTROCARDIOGRAM QT PROLONGED | 1 0.01 42.23 ELECTROLYTE IMBALANCE | 1 0.01 42.24 EMBOLISM | 2 0.02 42.26 EMPHYSEMA | 44 0.44 42.70 EMPYEMA | 1 0.01 42.71 ENCEPHALITIS HERPES | 1 0.01 42.72 ENDOMETRIAL CANCER RECURRENT | 1 0.01 42.73 ENDOMETRIOSIS | 8 0.08 42.81 ENTERITIS INFECTIOUS | 1 0.01 42.82 EPIDURAL ANAESTHESIA | 2 0.02 42.84 EPILEPSY | 46 0.46 43.30 ERECTILE DYSFUNCTION | 210 2.10 45.40 ERYSIPELAS | 6 0.06 45.46 ESSENTIAL HYPERTENSION | 14 0.14 45.60 ESSENTIAL TREMOR | 2 0.02 45.62 EWING'S SARCOMA METASTATIC | 1 0.01 45.63 EXOSTOSIS | 2 0.02 45.65 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 4 0.04 45.69 EXTRAPYRAMIDAL DISORDER | 2 0.02 45.71 FABRY'S DISEASE | 39 0.39 46.10 FACIAL PAIN | 2 0.02 46.12 FACIAL PALSY | 1 0.01 46.13 FACTOR VII DEFICIENCY | 2 0.02 46.15 FACTOR VIII DEFICIENCY | 7 0.07 46.22 FACTOR VIII INHIBITION | 1 0.01 46.23 FAILURE TO THRIVE | 1 0.01 46.24 FATIGUE | 3 0.03 46.27 FEBRILE NEUTROPENIA | 2 0.02 46.29 FIBROMYALGIA | 5 0.05 46.34 FISTULA | 1 0.01 46.35 FLATULENCE | 1 0.01 46.36 FLUID REPLACEMENT | 1 0.01 46.37 FLUID RETENTION | 2 0.02 46.39 FLUSHING | 1 0.01 46.40 FOLATE DEFICIENCY | 1 0.01 46.41 FOOD ALLERGY | 1 0.01 46.42 FOOT OPERATION | 1 0.01 46.43 FRACTURE | 3 0.03 46.46 FUNCTIONAL RESIDUAL CAPACITY DECREASED | 1 0.01 46.47 FUNGAEMIA | 1 0.01 46.48 FUNGAL INFECTION | 3 0.03 46.51 GALLBLADDER CANCER | 2 0.02 46.53 GASTRIC CANCER | 11 0.11 46.64 GASTRIC DISORDER | 7 0.07 46.71 GASTRIC MUCOSAL LESION | 2 0.02 46.73 GASTRIC ULCER | 29 0.29 47.02 GASTRIC ULCER HAEMORRHAGE | 1 0.01 47.03 GASTRIC VARICES | 3 0.03 47.06 GASTRITIS | 16 0.16 47.22 GASTRODUODENAL ULCER | 1 0.01 47.23 GASTROINTESTINAL DISORDER | 2 0.02 47.25 GASTROINTESTINAL HAEMORRHAGE | 1 0.01 47.26 GASTROINTESTINAL MOTILITY DISORDER | 3 0.03 47.29 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 47.30 GASTROOESOPHAGEAL REFLUX DISEASE | 36 0.36 47.66 GENERAL ANAESTHESIA | 2 0.02 47.68 GENERALISED ANXIETY DISORDER | 2 0.02 47.70 GIARDIASIS | 1 0.01 47.71 GINGIVAL RECESSION | 1 0.01 47.72 GLAUCOMA | 5 0.05 47.77 GLIOBLASTOMA | 3 0.03 47.80 GLIOBLASTOMA MULTIFORME | 13 0.13 47.93 GLOMERULONEPHRITIS | 1 0.01 47.94 GLOMERULONEPHRITIS PROLIFERATIVE | 1 0.01 47.95 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 47.98 GOUT | 8 0.08 48.06 GRANULOMA ANNULARE | 1 0.01 48.07 GROWTH HORMONE DEFICIENCY | 11 0.11 48.18 HAEMOCHROMATOSIS | 1 0.01 48.19 HAEMOPHILIA | 307 3.07 51.26 HAEMORRHAGE | 8 0.08 51.34 HEADACHE | 18 0.18 51.52 HEART DISEASE CONGENITAL | 2 0.02 51.54 HEART RATE INCREASED | 1 0.01 51.55 HEART TRANSPLANT | 8 0.08 51.63 HEART VALVE OPERATION | 2 0.02 51.65 HELICOBACTER INFECTION | 9 0.09 51.74 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 51.76 HEPATIC CIRRHOSIS | 2 0.02 51.78 HEPATIC FUNCTION ABNORMAL | 2 0.02 51.80 HEPATIC NEOPLASM MALIGNANT | 2 0.02 51.82 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 51.83 HEPATIC STEATOSIS | 1 0.01 51.84 HEPATITIS | 29 0.29 52.13 HEPATITIS B | 10 0.10 52.23 HEPATITIS C | 385 3.85 56.08 HEPATITIS C VIRUS | 17 0.17 56.25 HERPES SIMPLEX | 2 0.02 56.27 HERPES ZOSTER | 17 0.17 56.44 HIATUS HERNIA | 1 0.01 56.45 HIP ARTHROPLASTY | 1 0.01 56.46 HIP FRACTURE | 1 0.01 56.47 HIV INFECTION | 142 1.42 57.89 HIV TEST POSITIVE | 6 0.06 57.95 HODGKIN'S DISEASE | 21 0.21 58.16 HORDEOLUM | 1 0.01 58.17 HORMONE REPLACEMENT THERAPY | 121 1.21 59.38 HOT FLUSH | 2 0.02 59.40 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 1 0.01 59.41 HYPERCALCAEMIA | 1 0.01 59.42 HYPERCHOLESTEROLAEMIA | 181 1.81 61.23 HYPERKALAEMIA | 6 0.06 61.29 HYPERKERATOSIS | 1 0.01 61.30 HYPERLIPIDAEMIA | 67 0.67 61.97 HYPERPARATHYROIDISM PRIMARY | 1 0.01 61.98 HYPERPARATHYROIDISM SECONDARY | 3 0.03 62.01 HYPERPHOSPHATAEMIA | 4 0.04 62.05 HYPERSENSITIVITY | 16 0.16 62.21 HYPERTENSION | 256 2.56 64.77 HYPERTENSIVE HEART DISEASE | 3 0.03 64.80 HYPERTHYROIDISM | 2 0.02 64.82 HYPERTONIC BLADDER | 12 0.12 64.94 HYPERTRIGLYCERIDAEMIA | 3 0.03 64.97 HYPERURICAEMIA | 4 0.04 65.01 HYPOAESTHESIA | 1 0.01 65.02 HYPOCHOLESTEROLAEMIA | 1 0.01 65.03 HYPOGONADISM | 1 0.01 65.04 HYPOKALAEMIA | 4 0.04 65.08 HYPOPHARYNGEAL CANCER | 2 0.02 65.10 HYPOPITUITARISM | 4 0.04 65.14 HYPOTENSION | 3 0.03 65.17 HYPOTHYROIDISM | 16 0.16 65.33 HYSTERECTOMY | 1 0.01 65.34 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 65.35 ILEUS | 3 0.03 65.38 ILL-DEFINED DISORDER | 177 1.77 67.15 IMMUNOSUPPRESSANT DRUG THERAPY | 1 0.01 67.16 IMMUNOSUPPRESSION | 1 0.01 67.17 IMPAIRED GASTRIC EMPTYING | 2 0.02 67.19 IMPULSE-CONTROL DISORDER | 1 0.01 67.20 IN VITRO FERTILISATION | 1 0.01 67.21 INCONTINENCE | 1 0.01 67.22 INCREASED APPETITE | 1 0.01 67.23 INCREASED UPPER AIRWAY SECRETION | 1 0.01 67.24 INDUCTION OF ANAESTHESIA | 5 0.05 67.29 INFECTION | 11 0.11 67.40 INFECTION PROPHYLAXIS | 15 0.15 67.55 INFERTILITY | 3 0.03 67.58 INFLAMMATION | 9 0.09 67.67 INFLAMMATORY BOWEL DISEASE | 1 0.01 67.68 INFLUENZA | 33 0.33 68.01 INJURY | 5 0.05 68.06 INSOMNIA | 39 0.39 68.45 INSULIN-REQUIRING TYPE II DIABETES ME.. | 17 0.17 68.62 INTENTIONAL MISUSE | 3 0.03 68.65 INTENTIONAL SELF-INJURY | 1 0.01 68.66 INTERSTITIAL LUNG DISEASE | 4 0.04 68.70 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 68.71 INTERVERTEBRAL DISC DISORDER | 1 0.01 68.72 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 68.75 INTESTINAL POLYPECTOMY | 4 0.04 68.79 IRITIS | 1 0.01 68.80 IRON DEFICIENCY | 2 0.02 68.82 IRRITABILITY | 1 0.01 68.83 IRRITABLE BOWEL SYNDROME | 49 0.49 69.32 JOINT INJURY | 1 0.01 69.33 JUVENILE ARTHRITIS | 2 0.02 69.35 JUVENILE CHRONIC MYELOMONOCYTIC LEUKA.. | 1 0.01 69.36 KIDNEY INFECTION | 1 0.01 69.37 LABILE HYPERTENSION | 1 0.01 69.38 LABOUR INDUCTION | 2 0.02 69.40 LACRIMATION INCREASED | 1 0.01 69.41 LARGE INTESTINE CARCINOMA | 1 0.01 69.42 LARYNGOPHARYNGITIS | 2 0.02 69.44 LATEX ALLERGY | 1 0.01 69.45 LAXATIVE SUPPORTIVE CARE | 1 0.01 69.46 LEIOMYOSARCOMA | 8 0.08 69.54 LEISHMANIASIS | 1 0.01 69.55 LEUKAEMIA | 3 0.03 69.58 LEUKOPENIA | 1 0.01 69.59 LIMB INJURY | 1 0.01 69.60 LIP AND/OR ORAL CAVITY CANCER | 4 0.04 69.64 LIPIDS | 1 0.01 69.65 LIPIDS ABNORMAL | 1 0.01 69.66 LIPIDS INCREASED | 8 0.08 69.74 LIVER DISORDER | 1 0.01 69.75 LIVER FUNCTION TEST ABNORMAL | 1 0.01 69.76 LIVER TRANSPLANT | 6 0.06 69.82 LOCAL ANAESTHESIA | 2 0.02 69.84 LOCALISED INFECTION | 4 0.04 69.88 LOW DENSITY LIPOPROTEIN | 1 0.01 69.89 LOW DENSITY LIPOPROTEIN INCREASED | 5 0.05 69.94 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 69.97 LUMBAR SPINAL STENOSIS | 2 0.02 69.99 LUNG ADENOCARCINOMA | 1 0.01 70.00 LUNG CANCER METASTATIC | 3 0.03 70.03 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 3 0.03 70.06 LUNG DISORDER | 11 0.11 70.17 LUNG INJURY | 3 0.03 70.20 LUNG NEOPLASM | 1 0.01 70.21 LUNG NEOPLASM MALIGNANT | 29 0.29 70.50 LUPUS-LIKE SYNDROME | 1 0.01 70.51 LYMPH NODE TUBERCULOSIS | 7 0.07 70.58 LYMPHADENITIS | 1 0.01 70.59 LYMPHANGIOLEIOMYOMATOSIS | 1 0.01 70.60 LYMPHOMA | 5 0.05 70.65 LYMPHOMATOID PAPULOSIS | 1 0.01 70.66 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 70.67 MACULAR DEGENERATION | 2 0.02 70.69 MAINTENANCE OF ANAESTHESIA | 4 0.04 70.73 MAJOR DEPRESSION | 7 0.07 70.80 MALAISE | 1 0.01 70.81 MALARIA | 1 0.01 70.82 MALARIA PROPHYLAXIS | 6 0.06 70.88 MALE PATTERN BALDNESS | 2 0.02 70.90 MALIGNANT HISTIOCYTOSIS | 1 0.01 70.91 MALIGNANT MELANOMA | 7 0.07 70.98 MALNUTRITION | 1 0.01 70.99 MANIA | 1 0.01 71.00 MEDIASTINAL MASS | 4 0.04 71.04 MEDICATION ERROR | 1 0.01 71.05 MEMORY IMPAIRMENT | 6 0.06 71.11 MENINGITIS PNEUMOCOCCAL | 1 0.01 71.12 MENOMETRORRHAGIA | 1 0.01 71.13 MENOPAUSAL DISORDER | 1 0.01 71.14 MENOPAUSAL SYMPTOMS | 5 0.05 71.19 MENOPAUSE | 1 0.01 71.20 MENORRHAGIA | 4 0.04 71.24 MENSTRUATION IRREGULAR | 2 0.02 71.26 MENTAL DISORDER | 1 0.01 71.27 MESOTHELIOMA | 9 0.09 71.36 MESOTHELIOMA MALIGNANT | 2 0.02 71.38 METASTASES TO BONE | 5 0.05 71.43 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 71.44 METASTASES TO LARYNX | 1 0.01 71.45 METASTASES TO LIVER | 16 0.16 71.61 METASTASES TO LUNG | 9 0.09 71.70 METASTASES TO OVARY | 2 0.02 71.72 METASTASIS | 5 0.05 71.77 METASTATIC CARCINOMA OF THE BLADDER | 1 0.01 71.78 METASTATIC MALIGNANT MELANOMA | 2 0.02 71.80 METASTATIC NEOPLASM | 2 0.02 71.82 METASTATIC PAIN | 1 0.01 71.83 METASTATIC RENAL CELL CARCINOMA | 2 0.02 71.85 MICROALBUMINURIA | 1 0.01 71.86 MIGRAINE | 19 0.19 72.05 MIGRAINE PROPHYLAXIS | 2 0.02 72.07 MINERAL SUPPLEMENTATION | 3 0.03 72.10 MITRAL VALVE REPAIR | 2 0.02 72.12 MIXED CONNECTIVE TISSUE DISEASE | 3 0.03 72.15 MIXED HYPERLIPIDAEMIA | 2 0.02 72.17 MOOD ALTERED | 2 0.02 72.19 MOTION SICKNESS | 3 0.03 72.22 MOVEMENT DISORDER | 1 0.01 72.23 MUCOPOLYSACCHARIDOSIS I | 5 0.05 72.28 MUCOPOLYSACCHARIDOSIS IH | 4 0.04 72.32 MULTIPLE ALLERGIES | 4 0.04 72.36 MULTIPLE MYELOMA | 145 1.45 73.81 MULTIPLE SCLEROSIS | 236 2.36 76.17 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 76.18 MUSCLE RELAXANT THERAPY | 3 0.03 76.21 MUSCLE RIGIDITY | 1 0.01 76.22 MUSCLE SPASMS | 2 0.02 76.24 MUSCLE SPASTICITY | 4 0.04 76.28 MUSCLE STRAIN | 1 0.01 76.29 MUSCLE TIGHTNESS | 1 0.01 76.30 MUSCLE TWITCHING | 1 0.01 76.31 MUSCULAR WEAKNESS | 1 0.01 76.32 MUSCULOSKELETAL DISORDER | 2 0.02 76.34 MUSCULOSKELETAL PAIN | 10 0.10 76.44 MYALGIA | 1 0.01 76.45 MYASTHENIA GRAVIS | 2 0.02 76.47 MYCOBACTERIA BLOOD TEST POSITIVE | 6 0.06 76.53 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 7 0.07 76.60 MYCOBACTERIUM MARINUM INFECTION | 1 0.01 76.61 MYCOSIS FUNGOIDES | 5 0.05 76.66 MYELOPROLIFERATIVE DISORDER | 1 0.01 76.67 MYOCARDIAL INFARCTION | 20 0.20 76.87 MYOCARDIAL ISCHAEMIA | 5 0.05 76.92 NAIL TINEA | 7 0.07 76.99 NASAL CONGESTION | 1 0.01 77.00 NASAL SINUS CANCER | 1 0.01 77.01 NASOPHARYNGEAL CANCER | 4 0.04 77.05 NASOPHARYNGEAL SURGERY | 1 0.01 77.06 NASOPHARYNGITIS | 39 0.39 77.45 NAUSEA | 16 0.16 77.61 NECK INJURY | 1 0.01 77.62 NECK PAIN | 2 0.02 77.64 NEOPLASM | 1 0.01 77.65 NEOPLASM MALIGNANT | 13 0.13 77.78 NEOPLASM PROPHYLAXIS | 2 0.02 77.80 NEPHRECTOMY | 1 0.01 77.81 NEPHROTIC SYNDROME | 6 0.06 77.87 NERVE ROOT COMPRESSION | 2 0.02 77.89 NERVOUS SYSTEM DISORDER | 4 0.04 77.93 NEURALGIA | 2 0.02 77.95 NEUROENDOCRINE CARCINOMA | 2 0.02 77.97 NEUROMUSCULAR BLOCKADE | 4 0.04 78.01 NEUROPATHIC PAIN | 5 0.05 78.06 NEUROPATHY | 11 0.11 78.17 NEUROPATHY PERIPHERAL | 5 0.05 78.22 NEUTROPENIA | 3 0.03 78.25 NEUTROPHIL COUNT DECREASED | 2 0.02 78.27 NIGHT SWEATS | 1 0.01 78.28 NON-HODGKIN'S LYMPHOMA | 26 0.26 78.54 NON-HODGKIN'S LYMPHOMA RECURRENT | 5 0.05 78.59 NON-HODGKIN'S LYMPHOMA STAGE IV | 1 0.01 78.60 NON-SMALL CELL LUNG CANCER | 46 0.46 79.06 NON-SMALL CELL LUNG CANCER METASTATIC | 3 0.03 79.09 NON-SMALL CELL LUNG CANCER STAGE IV | 5 0.05 79.14 NUTRITIONAL SUPPORT | 3 0.03 79.17 OBESITY | 7 0.07 79.24 OBSESSIVE-COMPULSIVE DISORDER | 6 0.06 79.30 OBSTRUCTIVE AIRWAYS DISORDER | 6 0.06 79.36 OCULAR HYPERTENSION | 2 0.02 79.38 OEDEMA | 4 0.04 79.42 OEDEMA PERIPHERAL | 3 0.03 79.45 OESOPHAGEAL CANDIDIASIS | 1 0.01 79.46 OESOPHAGEAL CARCINOMA | 1 0.01 79.47 OESOPHAGITIS | 1 0.01 79.48 OESTROGEN REPLACEMENT THERAPY | 1 0.01 79.49 OFF LABEL USE | 1 0.01 79.50 ONYCHOMYCOSIS | 1 0.01 79.51 OPEN ANGLE GLAUCOMA | 2 0.02 79.53 OPHTHALMOLOGICAL EXAMINATION | 1 0.01 79.54 ORAL CONTRACEPTION | 4 0.04 79.58 ORAL INFECTION | 1 0.01 79.59 ORTHODONTIC PROCEDURE | 1 0.01 79.60 OSTEITIS DEFORMANS | 2 0.02 79.62 OSTEOARTHRITIS | 31 0.31 79.93 OSTEOMYELITIS | 3 0.03 79.96 OSTEOPENIA | 6 0.06 80.02 OSTEOPOROSIS | 323 3.23 83.25 OSTEOPOROSIS POSTMENOPAUSAL | 1 0.01 83.26 OSTEOPOROSIS PROPHYLAXIS | 1 0.01 83.27 OTITIS EXTERNA | 1 0.01 83.28 OTITIS MEDIA | 1 0.01 83.29 OTITIS MEDIA CHRONIC | 1 0.01 83.30 OVARIAN CANCER | 17 0.17 83.47 OVARIAN CANCER METASTATIC | 2 0.02 83.49 OVARIAN CYST | 1 0.01 83.50 PAIN | 124 1.24 84.74 PAIN IN EXTREMITY | 12 0.12 84.86 PAIN IN JAW | 1 0.01 84.87 PAIN MANAGEMENT | 4 0.04 84.91 PAIN PROPHYLAXIS | 1 0.01 84.92 PANCREATIC CARCINOMA | 15 0.15 85.07 PANCREATIC CARCINOMA METASTATIC | 4 0.04 85.11 PANCREATIC PSEUDOCYST | 1 0.01 85.12 PANCREATITIS ACUTE | 1 0.01 85.13 PANIC ATTACK | 4 0.04 85.17 PANIC DISORDER | 4 0.04 85.21 PARAESTHESIA | 1 0.01 85.22 PARANOIA | 1 0.01 85.23 PARANOID PERSONALITY DISORDER | 1 0.01 85.24 PARKINSON'S DISEASE | 9 0.09 85.33 PARTIAL SEIZURES | 5 0.05 85.38 PATENT DUCTUS ARTERIOSUS | 2 0.02 85.40 PELVIC PAIN | 1 0.01 85.41 PEPTIC ULCER | 2 0.02 85.43 PERIPHERAL OCCLUSIVE DISEASE | 3 0.03 85.46 PERIPHERAL VASCULAR DISORDER | 2 0.02 85.48 PERITONEAL DIALYSIS | 14 0.14 85.62 PERITONITIS | 1 0.01 85.63 PETIT MAL EPILEPSY | 4 0.04 85.67 PEYRONIE'S DISEASE | 1 0.01 85.68 PHARYNGITIS | 5 0.05 85.73 PHARYNGITIS STREPTOCOCCAL | 2 0.02 85.75 PHARYNGOLARYNGEAL PAIN | 10 0.10 85.85 PHLEBITIS | 1 0.01 85.86 PHLEBOTHROMBOSIS | 1 0.01 85.87 PIGMENTATION DISORDER | 1 0.01 85.88 PLANTAR FASCIITIS | 1 0.01 85.89 PLASMAPHERESIS | 1 0.01 85.90 PLEURAL MESOTHELIOMA | 1 0.01 85.91 PLEURAL MESOTHELIOMA MALIGNANT | 4 0.04 85.95 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 85.97 PNEUMONIA | 22 0.22 86.19 PNEUMONIA MYCOPLASMAL | 1 0.01 86.20 POLYARTHRITIS | 2 0.02 86.22 POLYMYALGIA | 1 0.01 86.23 POLYMYALGIA RHEUMATICA | 2 0.02 86.25 POLYSUBSTANCE DEPENDENCE | 1 0.01 86.26 POLYURIA | 2 0.02 86.28 POST HERPETIC NEURALGIA | 1 0.01 86.29 POST LAMINECTOMY SYNDROME | 3 0.03 86.32 POST PROCEDURAL COMPLICATION | 1 0.01 86.33 POST PROCEDURAL PAIN | 13 0.13 86.46 POST-TRAUMATIC STRESS DISORDER | 6 0.06 86.52 POSTOPERATIVE ANALGESIA | 3 0.03 86.55 POSTOPERATIVE CARE | 1 0.01 86.56 POSTPARTUM DEPRESSION | 2 0.02 86.58 POUCHITIS | 1 0.01 86.59 PRADER-WILLI SYNDROME | 1 0.01 86.60 PRE-ECLAMPSIA | 2 0.02 86.62 PRECOCIOUS PUBERTY | 1 0.01 86.63 PREMATURE EJACULATION | 2 0.02 86.65 PREMEDICATION | 8 0.08 86.73 PREOPERATIVE CARE | 1 0.01 86.74 PRODUCTIVE COUGH | 4 0.04 86.78 PROLACTINOMA | 1 0.01 86.79 PROPHYLAXIS | 39 0.39 87.18 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 14 0.14 87.32 PROPHYLAXIS AGAINST HIV INFECTION | 2 0.02 87.34 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 4 0.04 87.38 PROPHYLAXIS OF NAUSEA AND VOMITING | 15 0.15 87.53 PROSTATE CANCER | 22 0.22 87.75 PROSTATE CANCER METASTATIC | 3 0.03 87.78 PROSTATECTOMY | 1 0.01 87.79 PROSTATIC ADENOMA | 1 0.01 87.80 PROSTATISM | 1 0.01 87.81 PROSTATITIS | 2 0.02 87.83 PRURITUS | 2 0.02 87.85 PSEUDOMONAL SEPSIS | 1 0.01 87.86 PSEUDOMONAS INFECTION | 1 0.01 87.87 PSOAS ABSCESS | 1 0.01 87.88 PSORIASIS | 242 2.42 90.30 PSORIATIC ARTHROPATHY | 7 0.07 90.37 PSYCHIATRIC SYMPTOM | 1 0.01 90.38 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 90.40 PSYCHOTIC DISORDER | 11 0.11 90.51 PULMONARY CONGESTION | 2 0.02 90.53 PULMONARY EMBOLISM | 3 0.03 90.56 PULMONARY FIBROSIS | 2 0.02 90.58 PULMONARY HYPERTENSION | 16 0.16 90.74 PULMONARY TUBERCULOSIS | 4 0.04 90.78 PYODERMA GANGRENOSUM | 1 0.01 90.79 PYREXIA | 10 0.10 90.89 QUADRUPLE VESSEL BYPASS GRAFT | 1 0.01 90.90 RADICULITIS LUMBOSACRAL | 1 0.01 90.91 RADICULOPATHY | 1 0.01 90.92 RADIOTHERAPY | 27 0.27 91.19 RECTAL CANCER | 30 0.30 91.49 REFLUX OESOPHAGITIS | 6 0.06 91.55 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 5 0.05 91.60 RENAL ABSCESS | 1 0.01 91.61 RENAL CANCER METASTATIC | 3 0.03 91.64 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 91.66 RENAL DISORDER | 1 0.01 91.67 RENAL FAILURE | 1 0.01 91.68 RENAL FAILURE ACUTE | 1 0.01 91.69 RENAL FAILURE CHRONIC | 9 0.09 91.78 RENAL TRANSPLANT | 10 0.10 91.88 RESPIRATORY DISORDER | 2 0.02 91.90 RESPIRATORY TRACT INFECTION | 3 0.03 91.93 RESPIRATORY TRACT INFECTION BACTERIAL | 29 0.29 92.22 RESTLESS LEGS SYNDROME | 5 0.05 92.27 RETINAL DETACHMENT | 1 0.01 92.28 RHEUMATOID ARTHRITIS | 320 3.20 95.48 RHINITIS | 2 0.02 95.50 RHINITIS ALLERGIC | 7 0.07 95.57 RHINORRHOEA | 3 0.03 95.60 ROSACEA | 1 0.01 95.61 SAPHO SYNDROME | 1 0.01 95.62 SARCOIDOSIS | 3 0.03 95.65 SCAN | 2 0.02 95.67 SCAN BRAIN | 1 0.01 95.68 SCAN MYOCARDIAL PERFUSION | 1 0.01 95.69 SCAN WITH CONTRAST | 1 0.01 95.70 SCAR | 1 0.01 95.71 SCHIZOAFFECTIVE DISORDER | 14 0.14 95.85 SCHIZOPHRENIA | 69 0.69 96.54 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 96.55 SCHIZOPHRENIA, PARANOID TYPE | 12 0.12 96.67 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 2 0.02 96.69 SCIATIC NERVE INJURY | 1 0.01 96.70 SCIATICA | 4 0.04 96.74 SEASONAL ALLERGY | 4 0.04 96.78 SEDATION | 6 0.06 96.84 SEDATIVE THERAPY | 2 0.02 96.86 SEMINOMA | 3 0.03 96.89 SENILE DEMENTIA | 3 0.03 96.92 SEPSIS | 4 0.04 96.96 SICK SINUS SYNDROME | 1 0.01 96.97 SIMPLE PARTIAL SEIZURES | 1 0.01 96.98 SINUS DISORDER | 1 0.01 96.99 SINUS TACHYCARDIA | 1 0.01 97.00 SINUSITIS | 28 0.28 97.28 SJOGREN'S SYNDROME | 1 0.01 97.29 SKIN DISCOLOURATION | 1 0.01 97.30 SKIN REACTION | 1 0.01 97.31 SLEEP APNOEA SYNDROME | 1 0.01 97.32 SLEEP DISORDER | 9 0.09 97.41 SLEEP DISORDER THERAPY | 1 0.01 97.42 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 8 0.08 97.50 SMALL INTESTINE CARCINOMA METASTATIC | 1 0.01 97.51 SMOKER | 1 0.01 97.52 SMOKING CESSATION THERAPY | 6 0.06 97.58 SNEEZING | 1 0.01 97.59 SOMNOLENCE | 1 0.01 97.60 SPINAL ANAESTHESIA | 1 0.01 97.61 SPINAL COLUMN STENOSIS | 5 0.05 97.66 SPINAL COMPRESSION FRACTURE | 2 0.02 97.68 SPINAL CORD INJURY | 2 0.02 97.70 SPINAL CORD INJURY SACRAL | 1 0.01 97.71 SPINAL DISORDER | 1 0.01 97.72 SPINAL FRACTURE | 5 0.05 97.77 SPONDYLOLISTHESIS | 1 0.01 97.78 SQUAMOUS CELL CARCINOMA | 2 0.02 97.80 STAPHYLOCOCCAL INFECTION | 2 0.02 97.82 STEM CELL TRANSPLANT | 1 0.01 97.83 STENT PLACEMENT | 5 0.05 97.88 STOMATITIS | 1 0.01 97.89 SUDDEN HEARING LOSS | 1 0.01 97.90 SUICIDE ATTEMPT | 4 0.04 97.94 SUPERINFECTION LUNG | 1 0.01 97.95 SURGERY | 7 0.07 98.02 SURGICAL PROCEDURE REPEATED | 2 0.02 98.04 SWELLING | 1 0.01 98.05 SYNOVITIS | 1 0.01 98.06 SYSTEMIC ANTIBACTERIAL THERAPY | 2 0.02 98.08 SYSTEMIC CANDIDA | 3 0.03 98.11 SYSTEMIC LUPUS ERYTHEMATOSUS | 4 0.04 98.15 TACHYCARDIA | 1 0.01 98.16 TAKAYASU'S ARTERITIS | 1 0.01 98.17 TESTIS CANCER | 3 0.03 98.20 THERAPEUTIC PROCEDURE | 1 0.01 98.21 THERMAL BURN | 1 0.01 98.22 THROMBOSIS | 2 0.02 98.24 THROMBOSIS PROPHYLAXIS | 5 0.05 98.29 THYROID DISORDER | 2 0.02 98.31 TINEA PEDIS | 3 0.03 98.34 TOBACCO ABUSE | 1 0.01 98.35 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 3 0.03 98.38 TONSILLITIS | 2 0.02 98.40 TOOTH ABSCESS | 1 0.01 98.41 TOOTH INFECTION | 1 0.01 98.42 TRACHEOBRONCHITIS | 1 0.01 98.43 TRANSIENT ISCHAEMIC ATTACK | 2 0.02 98.45 TRANSITIONAL CELL CANCER OF THE RENAL.. | 1 0.01 98.46 TRANSPLANT REJECTION | 1 0.01 98.47 TRIGEMINAL NEURALGIA | 3 0.03 98.50 TRIPLE VESSEL BYPASS GRAFT | 1 0.01 98.51 TUBERCULOSIS | 3 0.03 98.54 TUBERCULOSIS PROPHYLAXIS | 2 0.02 98.56 TURNER'S SYNDROME | 6 0.06 98.62 TYPE IIA HYPERLIPIDAEMIA | 2 0.02 98.64 TYROSINAEMIA | 1 0.01 98.65 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 98.69 UPPER LIMB FRACTURE | 1 0.01 98.70 UPPER RESPIRATORY TRACT INFECTION | 19 0.19 98.89 UPPER RESPIRATORY TRACT INFLAMMATION | 7 0.07 98.96 URGE INCONTINENCE | 1 0.01 98.97 URINARY INCONTINENCE | 2 0.02 98.99 URINARY RETENTION | 6 0.06 99.05 URINARY TRACT INFECTION | 13 0.13 99.18 UROSEPSIS | 1 0.01 99.19 URTICARIA | 4 0.04 99.23 UTERINE CANCER | 2 0.02 99.25 UTERINE LEIOMYOSARCOMA | 2 0.02 99.27 VAGINAL HAEMORRHAGE | 1 0.01 99.28 VAGINAL LACERATION | 1 0.01 99.29 VARICOSE VEIN | 1 0.01 99.30 VASCULAR BYPASS GRAFT | 2 0.02 99.32 VASCULAR DEMENTIA | 8 0.08 99.40 VASCULAR PSEUDOANEURYSM | 1 0.01 99.41 VASCULITIS | 2 0.02 99.43 VENIPUNCTURE | 1 0.01 99.44 VENOUS ULCER PAIN | 3 0.03 99.47 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.48 VENTRICULAR SEPTAL DEFECT | 1 0.01 99.49 VERTICAL INFECTION TRANSMISSION | 6 0.06 99.55 VERTIGO | 3 0.03 99.58 VITAMIN SUPPLEMENTATION | 10 0.10 99.68 VITILIGO | 1 0.01 99.69 VOCAL CORD DISORDER | 1 0.01 99.70 VOMITING | 12 0.12 99.82 VULVOVAGINAL DRYNESS | 3 0.03 99.85 WEIGHT CONTROL | 1 0.01 99.86 WEIGHT DECREASED | 1 0.01 99.87 WHEEZING | 2 0.02 99.89 WHITE BLOOD CELL COUNT DECREASED | 1 0.01 99.90 WOUND | 1 0.01 99.91 WOUND INFECTION | 4 0.04 99.95 WOUND INFECTION STAPHYLOCOCCAL | 3 0.03 99.98 ZYGOMYCOSIS | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015